1. Home
  2. VISN vs ABSI Comparison

VISN vs ABSI Comparison

Compare VISN & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vistance Networks Inc. Common Stock

VISN

Vistance Networks Inc. Common Stock

N/A

Current Price

$3.84

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$7.60

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VISN
ABSI
Founded
1976
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VISN
ABSI
Price
$3.84
$7.60
Analyst Decision
Hold
Strong Buy
Analyst Count
4
12
Target Price
$5.67
★ $15.09
AVG Volume (30 Days)
★ 7.1M
4.3M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 412.50%
N/A
EPS Growth
★ 641.01
10.64
EPS
★ 29.48
N/A
Revenue
★ $1,931,600,000.00
$4,534,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.25
P/E Ratio
$0.14
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.89
$2.24
52 Week High
$19.91
$12.54

Technical Indicators

Market Signals
Indicator
VISN
ABSI
Relative Strength Index (RSI) 25.48 39.21
Support Level N/A $6.69
Resistance Level $6.76 $11.94
Average True Range (ATR) 0.25 0.92
MACD -0.09 -0.28
Stochastic Oscillator 1.79 5.47

Price Performance

Historical Comparison
VISN
ABSI

About VISN Vistance Networks Inc. Common Stock

Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Share on Social Networks: